AU2001285026A1 - Methods and compositions for use in the diagnosis and treatment of chronic immune disease - Google Patents
Methods and compositions for use in the diagnosis and treatment of chronic immune diseaseInfo
- Publication number
- AU2001285026A1 AU2001285026A1 AU2001285026A AU8502601A AU2001285026A1 AU 2001285026 A1 AU2001285026 A1 AU 2001285026A1 AU 2001285026 A AU2001285026 A AU 2001285026A AU 8502601 A AU8502601 A AU 8502601A AU 2001285026 A1 AU2001285026 A1 AU 2001285026A1
- Authority
- AU
- Australia
- Prior art keywords
- diagnosis
- compositions
- treatment
- methods
- immune disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000001684 chronic effect Effects 0.000 title 1
- 238000003745 diagnosis Methods 0.000 title 1
- 208000026278 immune system disease Diseases 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/44—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/916—Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
- G01N2333/922—Ribonucleases (RNAses); Deoxyribonucleases (DNAses)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Urology & Nephrology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Rheumatology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Rehabilitation Therapy (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09645071 | 2000-08-23 | ||
| US09/645,071 US6808936B1 (en) | 2000-08-23 | 2000-08-23 | Methods and compositions for use in the diagnosis and treatment of chronic immune disease |
| PCT/US2001/025796 WO2002015929A1 (en) | 2000-08-23 | 2001-08-16 | Methods and compositions for use in the diagnosis and treatment of chronic immune disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001285026A1 true AU2001285026A1 (en) | 2002-03-04 |
Family
ID=24587528
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001285026A Abandoned AU2001285026A1 (en) | 2000-08-23 | 2001-08-16 | Methods and compositions for use in the diagnosis and treatment of chronic immune disease |
Country Status (3)
| Country | Link |
|---|---|
| US (2) | US6808936B1 (en) |
| AU (1) | AU2001285026A1 (en) |
| WO (1) | WO2002015929A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6989239B2 (en) * | 2001-06-20 | 2006-01-24 | R.E.D. Laboratories, N.V./S.A. | Methods for diagnosis and treatment of chronic immune diseases |
| WO2006026837A1 (en) * | 2004-09-07 | 2006-03-16 | Patrick Englebienne | Diagnostic methods for measuring elastase activity levels |
| CN101175994A (en) * | 2004-10-21 | 2008-05-07 | 药品诊断学公司 | Stable metal/conductive polymer composite colloids and methods of making and using same |
| CA2740011A1 (en) * | 2008-10-10 | 2010-04-15 | Hemispherx Biopharma, Inc. | Treatment of chronic fatigue syndrome using selective agonists of toll-like receptor 3 (tlr3) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6130206A (en) | 1980-07-07 | 2000-10-10 | Hem Research, Inc. | Treating viral infections associated with chronic fatigue with dsRNA |
| WO1991000097A1 (en) | 1989-06-27 | 1991-01-10 | Hem Research, Inc. | Diagnosing and treating viral infections associated with chronic fatigue |
| US5776690A (en) | 1996-10-07 | 1998-07-07 | Vojdani; Aristo | Detection of chronic fatigue syndrome by decreased levels of RNase L inhibitor mRNA |
| US5985565A (en) | 1996-10-09 | 1999-11-16 | Temple University-Of The Commonwealth System Of Higher Education | Chronic fatigue syndrome diagnosis |
| US5830668A (en) | 1996-12-13 | 1998-11-03 | Immunosciences Lab, Inc. | Detection of chronic fatigue syndrome |
| US6080554A (en) | 1999-04-27 | 2000-06-27 | R.E.D. Laboratories, N.V. | Methods and compositions for use in characterizing multiple sclerosis disease activity in a subject |
-
2000
- 2000-08-23 US US09/645,071 patent/US6808936B1/en not_active Expired - Lifetime
-
2001
- 2001-08-16 WO PCT/US2001/025796 patent/WO2002015929A1/en not_active Ceased
- 2001-08-16 AU AU2001285026A patent/AU2001285026A1/en not_active Abandoned
-
2004
- 2004-05-13 US US10/845,777 patent/US20050009202A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20050009202A1 (en) | 2005-01-13 |
| US6808936B1 (en) | 2004-10-26 |
| WO2002015929A1 (en) | 2002-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU7722600A (en) | Compositions and methods for the diagnosis and treatment of immune disorders | |
| IL150628A0 (en) | Use of lipid conjugates in the treatment of disease | |
| AU2001271973A1 (en) | Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis | |
| AU2001236798A1 (en) | Optically-active nanoparticles for use in therapeutic and diagnostic methods | |
| AU2003243551A1 (en) | Use of an anti-endotoxin drug in the prevention and treatment of disease | |
| AU2003291609A1 (en) | Cb 1/cb 2 receptor ligands and their use in the treatment of pain | |
| AU2001259758A1 (en) | Interleukin-1 inhibitors in the treatment of diseases | |
| PT1757606E (en) | Xanthinderivatives for use as medical agents and the preparation thereof | |
| HUP0401023A3 (en) | Use of flibanserin in the treatment of sexual disorders | |
| HUP0400231A3 (en) | Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer | |
| AU2002308348A1 (en) | Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumours | |
| ZA200301204B (en) | Compositions and methods for the diagnosis and treatment of tumor | |
| AU5309600A (en) | Compositions and methods for the treatment and diagnosis of immune disorders | |
| AU2001264172A1 (en) | Methods and compositions for diagnosing chronic immune disease | |
| AU3632600A (en) | Compositions and methods for the treatment of immune related diseases | |
| AU2002243363A1 (en) | Use of aziridino-compounds in the treatment of immune dysfunctions | |
| AU2003286285A1 (en) | Use of fgf-18 in the diagnosis and treatment of memory disorders | |
| AU8678501A (en) | Compositions and methods for the diagnosis and treatment of tumor | |
| AU2003238242A1 (en) | Use of an anti-endotoxin drug in the prevention and treatment of disease | |
| HUP0400262A3 (en) | Glycopeptides, their preparation and use in the treatment of multiple sclerosis | |
| AU3434601A (en) | Compositions and methods for the treatment of immune related diseases | |
| EP1472273A4 (en) | Compositions and methods for the treatment of immune related diseases | |
| AU2001285026A1 (en) | Methods and compositions for use in the diagnosis and treatment of chronic immune disease | |
| AU2001253886A1 (en) | Methylxanthines in the diagnosis and treatment of autistic disorder | |
| AU2003245858A1 (en) | Uses of ngal-binding substances in the diagnosis and treatment of cancer diseases |